Shanghai Kaibao Pharmaceutical (300039)

Currency in CNY
6.67
-0.18(-2.63%)
Closed·
300039 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
300039 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.666.93
52 wk Range
4.907.60
Key Statistics
Bid/Ask
6.67 / 6.67
Prev. Close
6.85
Open
6.89
Day's Range
6.66-6.93
52 wk Range
4.9-7.6
Volume
55.77M
Average Volume (3m)
33.35M
1-Year Change
18.43%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300039 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Shanghai Kaibao Pharmaceutical Company Profile

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.

Employees
1225
Market
China

Compare 300039 to Peers and Sector

Metrics to compare
300039
Peers
Sector
Relationship
P/E Ratio
19.1x30.6x−0.5x
PEG Ratio
1.79−0.160.00
Price/Book
1.7x3.2x2.6x
Price / LTM Sales
5.1x4.8x3.3x
Upside (Analyst Target)
-11.6%40.3%
Fair Value Upside
Unlock5.3%4.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.36%
Dividend Yield
1.50%
Industry Median 1.51%
Annualised payout
0.10
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 15, 2025
EPS / Forecast
0.08 / --
Revenue / Forecast
400.64M / --
EPS Revisions
Last 90 days

300039 Income Statement

FAQ

What Stock Exchange Does Shanghai Kaibao Pharmaceutical Trade On?

Shanghai Kaibao Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Shanghai Kaibao Pharmaceutical?

The stock symbol for Shanghai Kaibao Pharmaceutical is "300039."

What Is the Shanghai Kaibao Pharmaceutical Market Cap?

As of today, Shanghai Kaibao Pharmaceutical market cap is 6.98B.

What Is Shanghai Kaibao Pharmaceutical's Earnings Per Share (TTM)?

The Shanghai Kaibao Pharmaceutical EPS (TTM) is 0.36.

From a Technical Analysis Perspective, Is 300039 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Shanghai Kaibao Pharmaceutical Stock Split?

Shanghai Kaibao Pharmaceutical has split 6 times.

How Many Employees Does Shanghai Kaibao Pharmaceutical Have?

Shanghai Kaibao Pharmaceutical has 1225 employees.

What is the current trading status of Shanghai Kaibao Pharmaceutical (300039)?

As of 14 Aug 2025, Shanghai Kaibao Pharmaceutical (300039) is trading at a price of 6.67, with a previous close of 6.85. The stock has fluctuated within a day range of 6.66 to 6.93, while its 52-week range spans from 4.90 to 7.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.